Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Systemic potassium homeostasis refers to the complex physiological processes that maintain the concentration of potassium ions (K+) within a narrow range in the extracellular fluid, which is critical for normal cellular function [1]. This regulation is primarily achieved through a balance between dietary intake, internal distribution between intracellular and extracellular compartments (mediated by the Na+/K+-ATPase pump), and renal or gastrointestinal excretion [2]. Potassium is the major intracellular cation, and its gradient across the cell membrane determines the resting membrane potential, making it essential for the excitability of nerve and muscle tissues, including the heart [3]. Disruptions in this balance lead to hyperkalemia or hypokalemia, both of which can cause fatal cardiac arrhythmias and neuromuscular dysfunction [4]. Therapeutic intervention often involves drugs that either promote potassium removal (binders or diuretics) or prevent its loss, frequently in the context of managing chronic kidney disease or heart failure where homeostatic mechanisms are impaired [5]. Hormones such as aldosterone and insulin play pivotal roles in shifting potassium into cells or promoting its renal secretion to prevent toxicity [2]. In clinical practice, monitoring serum potassium is a standard procedure for patients on cardiovascular or renal medications, as many of these therapies can inadvertently disrupt this delicate balance [3]. Modern pharmacological agents like patiromer and sodium zirconium cyclosilicate have improved the management of chronic hyperkalemia by binding potassium in the gastrointestinal tract [5]. Sources: [1] NIH Office of Dietary Supplements (https://ods.od.nih.gov/factsheets/Potassium-HealthProfessional/); [2] StatPearls, Physiology, Potassium (https://www.ncbi.nlm.nih.gov/books/NBK482465/); [3] Clinical Journal of the American Society of Nephrology (https://doi.org/10.2215/CJN.08580813); [4] Journal of the American Society of Nephrology (https://doi.org/10.1681/ASN.2014121177); [5] JAMA (https://doi.org/10.1001/jama.2014.15688).
Drugs modulate systemic potassium through various mechanisms including gastrointestinal potassium binding, renal excretion enhancement via diuretic action, or inhibition of the renin-angiotensin-aldosterone system (RAAS) [2, 5].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Systemic potassium homeostasis.